Skin and Connective Tissue Diseases

445 trials 165 recruiting

Filter these 445 trials by phase, country and sponsor.

Open in Search →

A Parallel-group (2-Arm), Randomized, Double-blind, 12-week Trial to Evaluate the Efficacy and Safety of MC2-25 Cream and MC2-25 Vehicle in… Not authorised

2022-500044-38-00 Chronic Kidney Disease associated Pruritus 4
Study to Evaluate the Efficacy and Safety of ATI-045 in Atopic Dermatitis Not authorised

2024-520302-19-00 Atopic dermatitis 4
Efficacy and Safety of ANB032 in the Treatment of Subjects with Atopic Dermatitis Not authorised

2023-503522-40-00 Atopic Dermatitis 4
Comparison of treatment efficacy in the patients with Systemic sclerOsis: dapagliFlozin vs. Tocilizumab – a randomized head to head study Not authorised

2025-523714-92-00 Systemic Sclerosis 4
IMPD-Q-only application Not authorised

2025-524730-26-00 prick test-induced itch 3
Metal Panel Patch Test Not authorised

2023-507972-35-00 Allergic contact dermatitis Eczema 5
A two-part study: open label, dose escalation phase aimed to evaluate the safety and tolerability of two different doses of allogeneic fibro… Pending

2025-522647-17-00 Refractory wounds 7
EFFECT OF DEXAMETASONE ON LOWER LIMB EDEMA IN PATIENTS UNDERTAKEN FOR TOTAL HIP ARTHROPLASTY Pending

2024-518133-28-00 POST -OPERATIVE LOWER LIMB EDEMA 6
Scar Remodeling after Burn Injury using Adipose-derived Allogeneic Stem Cells Pending

2024-519160-41-00 Hypertrophic scarring. 9
Frostbite Treatment Study comparing tPA and iloprost therapy Pending

2024-520291-10-01 Frostbite injury to extremities 6
CITY Pending

2024-520294-13-00 Cutaneous T-cell lymphomas (CTCL) 1
MERCURE study: MEthotrexate in ReCurrent dVIN Pending

2025-524373-17-00 dVIN caused by Lichen Sclerosus 6
Clinical Trial to Demonstrate the Safety and Efficacy of DUOFAG® Pending

2025-522752-45-00 Complicated skin wounds (wounds healing per secundam vi 10
A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of 250 mg lebrikizumab in patients with localized s… Pending

2025-524435-39-00 Localized Scleroderma 4
Arthritis interception with Guselkumab in subclinical psoriatic arthritis patients in clinical transition from skin to joint disease: a rand… Pending

2025-523551-54-00 PSORIATIC ARTHRITIS PATIENTS IN CLINICAL TRANSITION 6
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial to Evaluate the Efficacy and Safety of Eblasakimab in Male or Female Moder… Pending

2023-508329-28-00 Atopic Dermatitis 4
An interventional, Open-label Study to Evaluate the effect of lebrikizumab on eczema and Skin Barrier Function parameters in lesional and no… Pending

2024-519811-32-00 Atopic dermatitis 6
A Phase 2 trial to assess efficacy and safety of zasocitinib in moderate to severe hidradenitis suppurativa Pending

2025-522831-33-00 Hidradenitis Suppurativa 4
Fibroblast markers to tackle fibrosis in immune-mediated inflammatory diseases Pending

2025-522834-30-01 Idiopathic inflammatory myopathy (IIM) 4
Randomized double blind controlled trial comparing the safety and efficacy of apremilast versus placebo in severe forms of recurrent aphthou… Pending

2024-514659-13-00 Patients with severe forms of Recurrent Aphthous Stomat 5
Upadacitinib in adult patients with erosive mucosal Lichen Planus and Lichen Planopilaris. Pending

2025-522870-35-00 Lichen 4
PRESENT - Prophylaxis of Recurrent Erysipelas in lower limbs: compreSsion thErapy vs aNTibiotics and compression therapy. A non-inferiority,… Pending

2024-513801-30-00 Recurrent Erysipelas in lower limbs 5
Phase 2A–Evaluation of AUP1602-C with foam dressing as a new treatment for diabetic foot ulcers Pending

2024-519317-66-00 Diabetic Foot Ulcer 4
AliCsa; Efficacy of oral alitretinoin versus oral cyclosporine in patients with moderate to very severe hand eczema. A randomized prospecti… Pending

2024-515140-23-00 Hand eczema 6